<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>The 5th edition of Guideline on diagnosis and treatment of COVID‐19</italic> (
 <italic>the 5th Guideline for COVID‐19</italic>) published by NHC
 <xref rid="jmv25749-bib-0044" ref-type="ref">
  <sup>44</sup>
 </xref> shows that patients satisfying the following criteria are considered to have COVID‐19: (a) epidemiological history; and (b) clinical features of (i) fever and/or respiratory tract symptoms, (ii) radiographic evidence, (iii) low or normal white‐cell count or low lymphocyte count in the early period. Patients possessing an epidemiological history, consistent with any two clinical features, are diagnosed as suspected cases. Suspected cases are confirmed using any of the following pathogenic detection criteria: (a) positive for SARS‐CoV‐2 via respiratory or serum specimens examined with real‐time RT‐PCR; or (b) the full genome sequences of the virus from respiratory or serum specimens were identical to SARS‐CoV‐2 sequences.
</p>
